Live Breaking News & Updates on Prior therapies

Stay updated with breaking news from Prior therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rigel Announces Poster Presentations at the 65th American Society of Hematology Annual Meeting and Exposition

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the upcoming presentation of four posters highlighting data from their commercial...

California , United-states , Japan , Georgia , San-diego-convention-center , Texas , Houston , South-san-francisco , San-diego , Japanese , American , Jorgee-cortes

Gilead Sciences, Inc.: Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA

- Eight Presentations on Yescarta and TecartusAdvance Kite's Cell Therapy Leadership - - New Data Highlight Magrolimab's Potential to Alter the Tumor Microenvironment - Gilead Sciences, Inc. (Nasdaq:

Germany , California , United-states , Foster-city , Carol-ohear , Frank-neumann , Jacquie-ross , Brexucabtagene-autoleucel , Pivekimab-sunirine , Axicabtagene-ciloleucel , Cressida-robson , Meaghan-smith

Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA

– Eight Presentations on Yescarta® and Tecartus® Advance Kite’s Cell Therapy Leadership –

– New Data Highlight Magrolimab’s Potential to Alter the Tumor... | June 1, 2023

Germany , Foster-city , California , United-states , Decitabine-cedazuridine , Santa-monica , Carol-ohear , Frank-neumann , Pivekimab-sunirine , Axicabtagene-ciloleucel , Brexucabtagene-autoleucel , Drug-administration

Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023

– Data Across 30 Abstracts Reinforce Leadership in Metastatic Breast Cancer and Demonstrate Breadth of Pipeline Across Lung, Hematologic, Genitourinary, Gastrointestinal, Gynecological and... | May 17, 2023

Foster-city , California , United-states , Canada , Canadian , American , Domvanalimab-dom , Pembrolizumab-pembro , Etrumadenant-etruma , Axicabtagene-ciloleucel , Zimberelimab-zim , Frank-neumann

Sermonix Pharmaceuticals' Phase 2 Lasofoxifene Trial Poster

Guiding Researchers and Advocates to Scientific Partnerships (GRASP) launched in 2019 to unite patient advocates, physicians and researchers through...

United-states , Chicago , Illinois , American , Abema-verzenio , Paul-plourde , Abemaciclib-abema , Elaine-davidson-nemzer , Elizabeth-attias , Dsenthil-damodaran , Glenn-garmont , Eli-lilly